More than 10 million Americans had received their first dose of a COVID-19 vaccine as of Wednesday, according to the US Centers for Disease Control and Prevention, as the year-old pandemic roared on unchecked.
The United States reached 10.2 million inoculations one day after the CDC and Trump administration gave new guidance to US states on who should receive the shots first. Strict rules putting healthcare workers first in line had slowed the rollout.
Now states are urged to vaccinate anyone over 65 as well.
California moved on Wednesday to do just that, designating all individuals 65 and older eligible to begin receiving vaccines, adding 6.6 million people to the rolls of those qualified to be immunized, Governor Gavin Newsom said.
The move bumps senior citizens, regardless of whether they have underlying medical conditions, to the top of the priority list for vaccine recipients, just behind front-line healthcare workers and residents and staff of nursing homes.
California, like many states, has struggled to use up as much vaccine as it received in initial allotments from the federal government, administering only about a third of the nearly 2.5 million doses shipped to the state as of Monday.
Newsom has set a goal of inoculating 1 million more Californians by the end of this week with the first shot of the two-dose vaccine.
He also said the state would launch a new system next week for notifying people when they become eligible for the vaccine, and to register for notification by email or text.
The latest push to spur the most ambitious mass immunization campaign in US history came as the nation set a new record for coronavirus deaths in one day, with 4,336 fatalities on Tuesday, according to a Reuters tally.
Health and Human Services Secretary Alex Azar on Tuesday said the administration was releasing its full stockpile of two vaccines approved for emergency use, including some that had been held in reserve to make sure that second doses could be given on schedule.
Nearly 30 million doses of the vaccines, manufactured by Moderna and Pfizer with its German partner BioNTech, have been released to US states, which have used only about one-third of them.
Johnson & Johnson said on Wednesday that the pharmaceutical company was on track to roll out its single-shot vaccine in March.
In an interview with Reuters on Tuesday, Dr. Paul Stoffels also said J&J expected to meet its stated target of delivering 1 billion doses of its vaccine by the end of this year as the company ramps up production.
Political leaders and health officials nationwide have scrambled in recent days to push out more vaccines to their residents, many lowering the age requirement to 65. California and New York have both pledged to inoculate one million residents this month.